Thursday, October 22, 2009 12:45:42 AM
IMO... we have a few days to trend around here, then gradual rise in PPS in anticipation of upcoming event in the 4th quarter;
PDMI time is now in the 4th Quarter of 2009. PDMI could be a significant buyout target for big Pharma (Alcon or Bausch & Lomb). Key Forward Looking Events for PDMI are;
1) They have Multiple ophthalmic products,
2) 1 pending FDA decision per 10Q (Sales of surgical products are at a standstill pending FDA approval of the Photon TM laser system),
3) CPT-11 code for reimbursement (“ The Blood Flow Analyzer™ is expected to have a new CPT reimbursement code for Medicare insurance providers issued before the end of 2009”).
4) A big boon for the company is that Paradigm Medical has announced plans to Release Its New Corneal Topographer, the Paravue, in the United States Market! That will occur in the 4th quarter.
Need more time... I wish the markets were open 24 hours a day....
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
